Return-Path: <> Delivered-To: transitmeftah@cp.itech.dz Received: from cp.itech.dz by cp.itech.dz with LMTP id 0FRrLv+kQmlKNwAAYdxLKw (envelope-from <>) for ; Wed, 17 Dec 2025 12:41:35 +0000 Return-path: <> Envelope-to: a.boughazi.sk@transitmeftah.com Delivery-date: Wed, 17 Dec 2025 12:41:35 +0000 Received: from mail-westus3azon11021116.outbound.protection.outlook.com ([40.107.208.116]:41904 helo=PH0PR06CU001.outbound.protection.outlook.com) by cp.itech.dz with esmtps (TLS1.3) tls TLS_AES_256_GCM_SHA384 (Exim 4.97.1) id 1vVqqW-000000003hy-3CfV for a.boughazi.sk@transitmeftah.com; Wed, 17 Dec 2025 12:41:35 +0000 ARC-Seal: i=1; a=rsa-sha256; s=arcselector10001; d=microsoft.com; cv=none; b=vx/77zroX3IiDfqnZNSwCpveO8EDwmARJPWYCKsUOUQ1UcoYoNDF/m9Xkj/lwZaZw8djwPNpgjJLaTKvRO/eQOTiU0B+BiYvxxnt0tXwkZcHO39kPc+X/kygVZv30RiAWhFowA8iWXsTTDQNDtOsnFs3xx1sOZg5B2kw6TPw3D+6pq9Kr3qDRR4xIK/lFRAT1XQxdASvYhXjxRQt/ERqmo0VIoaMB7150pN3D4zVaUAnW7koJD0kqlcQd4pGOSiQQyk53WeNiiTxF+5zCH/k5TySoDPKGayH4olpbzCB9QgIfuIM9Wv5F7E7KhxhMngWz8NFcYYWRBPV9W1D14WkoA== ARC-Message-Signature: i=1; a=rsa-sha256; c=relaxed/relaxed; d=microsoft.com; s=arcselector10001; h=From:Date:Subject:Message-ID:Content-Type:MIME-Version:X-MS-Exchange-AntiSpam-MessageData-ChunkCount:X-MS-Exchange-AntiSpam-MessageData-0:X-MS-Exchange-AntiSpam-MessageData-1; bh=cd08rXEy/DYw5qt2O9/GIpsB36l1iKWF5Y/FwKPNj3w=; b=AMsKFE/HaWaiYKjm4jMBT5aGqehVKw8kPyX0G55kuFCYUCR3XzXC1jN7+bqQh6fUvGlTx/DQiWFgsHhk2k6vAx3e4wzLYGbkvJ3qcUGHBUODWbUZ1HG8ymwpYJDKOz27pQlRJEh3rBV/iBCcGlJopcaFI+qjjVCO/wURuZhznZ9v0m01a/d2makJaSY65UDmnxX24xAwumv/BaznJOqu2DmCcHfKCzcKVCVuFnbqdVsSnwyFVbha/KKs1Mpet+EJtKNMyfq76RAtG++l4S6Wn9CXZQwkyoj73ouu+MsOYwyc9ejcU+rKfnruGpfqxtq5eEJQlXRL+/UhT66N0Upg0Q== ARC-Authentication-Results: i=1; mx.microsoft.com 1; spf=none; dmarc=pass action=none header.from=pantalla.us.com; dkim=pass header.d=pantalla.us.com; arc=none DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed; d=pantalla.us.com; s=selector1; h=From:Date:Subject:Message-ID:Content-Type:MIME-Version:X-MS-Exchange-SenderADCheck; bh=cd08rXEy/DYw5qt2O9/GIpsB36l1iKWF5Y/FwKPNj3w=; b=bqsUVlhaOmfvNjEqlRD94zQ38Md9sxbCvnGrt5sCF/6X96mg7tONI0YQx34kV8qoRSZoIWqItR9s7/l8Hrf8haPfLBeXJh3Nl0ongu/WlBjJOa0MU4GD8f/pDMfAK6cDJlF6By0sXdBKXM3L7nZXiWkTUL6Kwb4IXhVfZm8UFe5dJI25ptuqtMd9UK9TmI2rZhX9xFC+i4Q6/UFYBFGgNdG4aAfPh3dN9kZm2osW4nqzz7D5z5pwk3d8WJfmqA4CA909M714nfeirx80wrl2RmSVl01j6T0rVfkIXLQZJ8yBM8NRk/fntrVVoroYsm/sWjnqAgdp+A65P9N2dL8GVA== Received: from SJ2PR02MB9391.namprd02.prod.outlook.com (2603:10b6:a03:4c5::17) by CH8PR02MB10993.namprd02.prod.outlook.com (2603:10b6:610:2c1::6) with Microsoft SMTP Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.20.9434.6; Wed, 17 Dec 2025 12:40:52 +0000 Received: from SJ2PR02MB9391.namprd02.prod.outlook.com ([::1]) by SJ2PR02MB9391.namprd02.prod.outlook.com ([fe80::6973:154a:2efe:46a7%5]) with Microsoft SMTP Server id 15.20.9434.001; Wed, 17 Dec 2025 12:40:52 +0000 From: Medvi Weight Loss To: "a.boughazi.sk@transitmeftah.com" Subject: Drop Pounds While Everyone Else Gains Thread-Topic: Drop Pounds While Everyone Else Gains Thread-Index: AQHcb1JgGqqrXcWt3UmdSwwaQzpAPbUlxh0L Date: Wed, 17 Dec 2025 12:40:52 +0000 Message-ID: <742e8bc8120e4f1f9312d525f841bb52@SJ2PR02MB9391.namprd02.prod.outlook.com> References: a.boughazi.sk@transitmeftah.com In-Reply-To: X-MS-Has-Attach: X-Auto-Response-Suppress: All X-MS-Exchange-Inbox-Rules-Loop: elnorarosina.6698@pantalla.us.com X-MS-TNEF-Correlator: authentication-results: dkim=none (message not signed) header.d=none;dmarc=none action=none header.from=pantalla.us.com; x-ms-exchange-parent-message-id: auto-submitted: auto-generated x-ms-exchange-generated-message-source: Mailbox Rules Agent x-ms-publictraffictype: Email x-ms-traffictypediagnostic: SJ2PR02MB9391:EE_|CH8PR02MB10993:EE_ x-ms-office365-filtering-correlation-id: 11c613da-b93f-4724-7c59-08de3d6983c7 x-ms-exchange-senderadcheck: 1 x-ms-exchange-antispam-relay: 0 x-microsoft-antispam: BCL:0;ARA:13230040|376014|10070799003|366016|1800799024|4022899009|8096899003|3122999012; x-microsoft-antispam-message-info: =?us-ascii?Q?ciKomucreUYht7pUyEk9bfsBlqNSrDZbnhRr4IwYzhNfwYxm25tmpTNqx+tY?= =?us-ascii?Q?cCWzO+owM+FdCwgmIfwcrh/zx8xpIVNx3+lxryyQlJNYd+hWIdBN+3tHewMW?= =?us-ascii?Q?DOWwihMYmb/4oVi1VRsF3r21KsgKaSEYmSXuoO/DKPBuPJy0JAxfRiFsPdPe?= =?us-ascii?Q?iYX2yfHDHIO0x0Je25dYYdxE9EiiLJiruJQAQ2RUrfvI3FX0owAiWvyJXyGx?= =?us-ascii?Q?Bhlq/yy55PKc9eCpQ0zoRAXTxtj7FfrDF1RnKd1EZhXIUCGPh+E034ToFT7A?= =?us-ascii?Q?SzeSWe6/z1jzWjteSlvIjxDIcr0vT1iM8YXXZwiyQkvWspzJHKFD/LnH0hVm?= =?us-ascii?Q?tcs5rlBdZlg9uFt8SOjG9YTItGPDy436zJ4qCsulB/5ZsPxSo3iKzWP312j0?= =?us-ascii?Q?V9irY5NoWKCuoz+64U9JRdE/Lg6fIw4b/qrm62yqpIoQWtRDYs5eGmAFFOJ0?= =?us-ascii?Q?24PQjGj6k8Vh7NhqSQrN7QNR4IvV+KAyKPZtIje/KC4Timb2DTei7Q31iT/4?= =?us-ascii?Q?E7WTPgufSsOjCeSkJRE2NQKInNinRX2fNeKAE4VGQdcB9OFycHBl1kHSeBYk?= =?us-ascii?Q?rdOgD4wY7SjSUWtYP+90bpj7GZDrvG6K9eOtEOYefBRz2QGKkygNFbSMeBtE?= =?us-ascii?Q?iJ515HSJXm0eXkMNDHfrYbIertdmDlT4WqNgLRCZ/eK4QJJmkEpg5UCi82hF?= =?us-ascii?Q?rsNpIWEvvJLoI5S3U1ammR74Pgfj0wDxIRy/SOfqtSMtk3g59/fZ99BlFWZK?= =?us-ascii?Q?4w0sgGcpRZlXiIlxQi1ENDwX91WvZteTruchSlruFZkIqc9sFWfC0Ybwbfrr?= =?us-ascii?Q?ht2XIlU36X8MQtDEF10MDe+zJZXrN9M2ecIu8Z6RnwIkEHmsAxBR1+RDumMH?= =?us-ascii?Q?sptcm7iO3llwBYi02Zc6prH90f/Ai3tnVVlI6u0xqYXmclp1YdDexF687jYV?= =?us-ascii?Q?dk/CBEIlIkjer4l5y1iR/NVkBvoFDfserf+grrjp5Jryu45pPWIfBIo0lXsI?= =?us-ascii?Q?EqT2kDsNegaU5f8gZYWMYw5Oql2nZeghK6n12jwVUxD+OB6NFda1JqotA7pC?= =?us-ascii?Q?YFrzhARgecSS7KUJ8xs1s7zZ8SlDcBZKzl3RuNSWX+3+9buR5P8sYkiQQO9C?= =?us-ascii?Q?DNhAB7lHsfD2586l5jXINZomSSQsnRzZLwQbL6oT/lVudzN/S4LzeDBbrwrl?= =?us-ascii?Q?a/a4u/LBUqJ2BZwPZI2ipWEtJa/A1CWqFyI8lMaZbgYy/QQwU9MuFd3ZcOFj?= =?us-ascii?Q?sJ7Gfyw9J9RliLsho9OX93IedbMcn3lXb5XR1PWJeTRqhE+oYgcvSOg2muuY?= =?us-ascii?Q?/WfODtMq0dfdX5Snua6PINBS1dMhBBGGnQQelp6wFxdtOJeKpH74HKe9r1Ss?= =?us-ascii?Q?4IkgawIsDvOqXQIpqEX6ne800yH4tdTvPlgUVnecdVURmt791Q=3D=3D?= x-forefront-antispam-report: CIP:255.255.255.255;CTRY:;LANG:en;SCL:1;SRV:;IPV:NLI;SFV:NSPM;H:SJ2PR02MB9391.namprd02.prod.outlook.com;PTR:;CAT:NONE;SFS:(13230040)(376014)(10070799003)(366016)(1800799024)(4022899009)(8096899003)(3122999012);DIR:OUT;SFP:1102; x-ms-exchange-antispam-messagedata-chunkcount: 1 x-ms-exchange-antispam-messagedata-0: ZMqiZAlm1Qks76IGOib8FkhqFlKZKvTS+MBtJbip0vexanCLdBrLaywbYiaS+EE5yrN+yE5SdHFFSUUyNJmjqLRdQ4EvnebKMaTzN8xClTTX/KEziNl2RfAp1Q5N/qHkigfeBO7fdeO754OQU7dMLZqXGFHH0cqbTARibXbooz7eL+BiwBnPsKI0692H0UES85QbI4mvhRdEgPYh+w4RiLT85kYjapoK2dDajsKiIrv/cHijMFIXpxHQwLTSWntLHwB3wPAhuNDLluziaO9BtfD3FfimP5MnpSI0QrXRUwREQbHiy0wfkqwXqePYe1fT Content-Type: multipart/alternative; boundary="_000_742e8bc8120e4f1f9312d525f841bb52SJ2PR02MB9391namprd02pr_" MIME-Version: 1.0 X-OriginatorOrg: pantalla.us.com X-MS-Exchange-CrossTenant-AuthAs: Internal X-MS-Exchange-CrossTenant-AuthSource: SJ2PR02MB9391.namprd02.prod.outlook.com X-MS-Exchange-CrossTenant-Network-Message-Id: 11c613da-b93f-4724-7c59-08de3d6983c7 X-MS-Exchange-CrossTenant-originalarrivaltime: 17 Dec 2025 12:40:52.4550 (UTC) X-MS-Exchange-CrossTenant-fromentityheader: Hosted X-MS-Exchange-CrossTenant-id: a0255dc8-40b1-4756-9593-3235e0bd22db X-MS-Exchange-Transport-CrossTenantHeadersStamped: CH8PR02MB10993 X-Spam-Status: No, score=2.3 X-Spam-Score: 23 X-Spam-Bar: ++ X-Ham-Report: Spam detection software, running on the system "cp.itech.dz", has NOT identified this incoming email as spam. The original message has been attached to this so you can view it or label similar future email. If you have any questions, see root\@localhost for details. Content preview: MEDVi Get Ozempic in the U.S. Ozempic helps lower A1C. Get approved with this quiz, no insurance needed. Content analysis details: (2.3 points, 5.0 required) pts rule name description ---- ---------------------- -------------------------------------------------- 0.0 URIBL_BLOCKED ADMINISTRATOR NOTICE: The query to URIBL was blocked. See http://wiki.apache.org/spamassassin/DnsBlocklists#dnsbl-block for more information. [URIs: storage.googleapis.com] 0.0 URIBL_DBL_BLOCKED ADMINISTRATOR NOTICE: The query to dbl.spamhaus.org was blocked. See https://www.spamhaus.org/returnc/vol/ [URIs: storage.googleapis.com] 0.0 RCVD_IN_ZEN_BLOCKED RBL: ADMINISTRATOR NOTICE: The query to zen.spamhaus.org was blocked. See https://www.spamhaus.org/returnc/vol/ [40.107.208.116 listed in zen.spamhaus.org] 0.0 RCVD_IN_VALIDITY_RPBL_BLOCKED RBL: ADMINISTRATOR NOTICE: The query to Validity was blocked. See https://knowledge.validity.com/hc/en-us/articles/20961730681243 for more information. [40.107.208.116 listed in bl.score.senderscore.com] 0.0 RCVD_IN_VALIDITY_CERTIFIED_BLOCKED RBL: ADMINISTRATOR NOTICE: The query to Validity was blocked. See https://knowledge.validity.com/hc/en-us/articles/20961730681243 for more information. [40.107.208.116 listed in sa-accredit.habeas.com] 0.0 URIBL_ZEN_BLOCKED ADMINISTRATOR NOTICE: The query to zen.spamhaus.org was blocked. See https://www.spamhaus.org/returnc/vol/ [URIs: pantalla.us.com] 2.2 KAM_STORAGE_GOOGLE URI: Google Storage API being abused by spammers 0.0 HTML_FONT_LOW_CONTRAST BODY: HTML font color similar or identical to background 0.0 HTML_MESSAGE BODY: HTML included in message -0.1 DKIM_VALID Message has at least one valid DKIM or DK signature 0.1 DKIM_SIGNED Message has a DKIM or DK signature, not necessarily valid -0.1 DKIM_VALID_AU Message has a valid DKIM or DK signature from author's domain 0.1 KAM_UNSUB1 Unsubscription Spams X-Spam-Flag: NO --_000_742e8bc8120e4f1f9312d525f841bb52SJ2PR02MB9391namprd02pr_ Content-Type: text/plain; charset="us-ascii" Content-Transfer-Encoding: quoted-printable MEDVi Get Ozempic in the U.S. Ozempic helps lower A1C. Get approved with this quiz, no insurance needed. See My Plan What's Included? * Prescription to Wegovy or Ozempic medication * Telehealth doctor appointment & 1-on-1 dietician guidance * Weekly updated diet plan based on metabolism * Daily nutrition curriculum * Metabolic test report If you wish to unsubscribe from future mailings please click here or write to: 337 Garden Oaks Blvd #67967, Houston, TX 77018 opt-out. --_000_742e8bc8120e4f1f9312d525f841bb52SJ2PR02MB9391namprd02pr_ Content-Type: text/html; charset="us-ascii" Content-Transfer-Encoding: quoted-printable Ozempic Offer
MEDVi



Get Ozempic in the U.S.
Ozempic = helps lower A1C.

Get approved wi= th this quiz, no insurance needed.

What's Included?
  • Prescription to Wegovy or Ozempic medication
  • Telehealth doctor = appointment & 1-on-1 dietician guidance
  • Weekly updated diet pla= n based on metabolism
  • Daily nutrition curriculum
  • Metabolic = test report
If you wish to unsubscribe from future mailings please click here or write to:
337 Garden Oaks Blvd #67967, Houston, TX 77018
--_000_742e8bc8120e4f1f9312d525f841bb52SJ2PR02MB9391namprd02pr_--